The mammalian target of rapamycin (mTOR) kinase is a master regulator of cellular, developmental, and metabolic processes. Deregulation of mTOR signaling is implicated in numerous human diseases including cancer and diabetes. mTOR functions as part of either of the two multisubunit complexes, mTORC1 and mTORC2, but molecular details about the assembly and oligomerization of mTORCs are currently lacking. We use the single-molecule pulldown (SiMPull) assay that combines principles of conventional pulldown assays with single-molecule fluorescence microscopy to investigate the stoichiometry and assembly of mTORCs. After validating our approach with mTORC1, confirming a dimeric assembly as previously reported, we show that all major components of mTORC2 exist in two copies per complex, indicating that mTORC2 assembles as a homodimer. Interestingly, each mTORC component, when free from the complexes, is present as a monomer and no single subunit serves as the dimerizing component. Instead, our data suggest that dimerization of mTORCs is the result of multiple subunits forming a composite surface. SiMPull also allowed us to distinguish complex disassembly from stoichiometry changes. Physiological conditions that abrogate mTOR signaling such as nutrient deprivation or energy stress did not alter the stoichiometry of mTORCs. On the other hand, rapamycin treatment leads to transient appearance of monomeric mTORC1 before complete disruption of the mTOR-raptor interaction, whereas mTORC2 stoichiometry is unaffected. These insights into assembly of mTORCs may guide future mechanistic studies and exploration of therapeutic potential. mTOR | mTORC | single molecule | stoichiometry | rapamycin
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mTOR | mTORC | single molecule | stoichiometry | rapamycin T he mammalian target of rapamycin (mTOR) is a master regulator of crucial cellular and developmental processes. As a serine/threonine protein kinase belonging to the phosphatidylinositol-3-kinase (PI3K)-related kinase family, mTOR integrates the sensing of nutrients, growth factors, oxygen, energy, and different types of stress to regulate a myriad of biological processes such as cell growth, proliferation, differentiation, and metabolism (1) . mTOR functions as part of at least two biochemically and functionally distinct complexes-mTORC1 and mTORC2 (2) . mTORC1, better characterized of the two complexes, is the rapamycin-sensitive complex, composed of the proteins raptor and mLST8, and it is regulated by the inhibitory proteins PRAS40 and DEPTOR (2, 3) . mTORC1 is activated by nutrients (such as amino acids), growth factors, and cellular energy among other stimuli (1, 2) . mTORC2 contains rictor, mLST8, and mSin, as well as the negative regulator DEPTOR (2, 3) .
PI3K-related kinases (PIKKs) such as ataxia telangiectasia mutated (ATM), ATM and Rad3-related protein (ATR), and DNA-dependent protein kinase (DNA-PK) are known to oligomerize (4) (5) (6) . Biochemical and genetic analyses have identified self-association of mTOR and its orthologs in yeast and Drosophila (7) (8) (9) (10) . A cryoelectron microscopy (cryo-EM) study revealed that mTORC1 self-associates into a dimeric structure (11) . Oligomerization of mTORC1 has been reported to be sensitive to nutrient status based on biochemical analyses of recombinant proteins (10, 12) . Consensus is lacking on the oligomeric state of mTORC2, which has been proposed to be monomeric, dimeric, or multimeric (7, 10, 13, 14) . High-resolution structural analysis of mTORC2 has not been possible thus far, likely owing to its large size and multiplicity of interaction partners.
Ensemble biochemical methods have inherent limitations in analyzing multicomponent heterogeneous protein assemblies. These methods do not directly reveal the stoichiometry of interaction and offer low-resolution estimates of the sizes of protein complexes. Additionally, the lengthy procedures often associated with biochemical characterization may lead to loss or alteration of physiological protein complexes. We recently reported a single-molecule pulldown (SiMPull) technology that combines the principles of conventional pulldown assays with single-molecule fluorescence microscopy (15) . In SiMPull, protein complexes are pulled down from freshly lysed cells directly onto chambers for single-molecule fluorescence microscopy. When proteins are stoichiometrically labeled for example using fluorescent protein tags, SiMPull can reveal the stoichiometry of the protein complexes via single-molecule fluorescence photobleaching step analysis (15) .
We have used SiMPull to investigate the oligomeric assembly of mTORCs. Upon validating our approach by demonstrating dimeric assembly of mTORC1, we find that mTORC2 is also dimeric and contains two molecules of mTOR and rictor per complex. Individual mTORC components are predominantly monomeric, but under physiological conditions there is no evidence of monomeric interaction between mTOR and raptor or rictor. Multicolor imaging of individual complexes revealed that although the two complexes are predominantly distinct, small fractions of mTORC1 and mTORC2 components coexist in the same complex. Physiological perturbations that abrogate mTOR signaling had no effect on the stoichiometry of mTOR complexes, indicating that inhibition of mTOR signaling can be
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achieved without requiring disassembly of mTOR complexes or changing their oligomeric state. On the other hand, treatment with rapamycin led to transient mTOR-raptor complexes containing one mTOR before complete disassembly of the interaction, whereas mTORC2 stoichiometry was unaffected.
Results
Assay Validation and mTORC1 Stoichiometry. To study mTOR complexes by SiMPull, we deemed it important to establish a system where a fluorescently tagged mTOR can incorporate into endogenous complexes. To that end, we established a cell line stably expressing YFP-mTOR in which the endogenous mTOR was silenced by short hairpin RNA (Fig. 1A , henceforth called "YFP-mTOR stable cell line"). The YFP-mTOR protein associated with endogenous raptor and rictor (Fig. 1A) . More importantly, the cell line faithfully recapitulated known regulations of mTOR signaling, such as insulin-and serum-stimulated phosphorylation of mTORC1 targets S6K1 and 4E-BP1, and mTORC2 target Akt, as well as amino acid dependence of S6K1 and 4E-BP1 phosphorylation (Fig. 1B and Fig. S1A ). When cell lysates from this line were applied to single-molecule imaging chambers coated with an antibody against raptor, YFPmTOR fluorescence spots were observed, well above the background level of fluorescence seen in the control channel without the antibody ( Fig. 1 C and D) , illustrating specific pulldown of mTOR in complex with raptor, or mTORC1.
To assess the sensitivity of SiMPull, we compared detection of YFP-mTOR by Western blotting and by SiMPull with cell lysates at the same concentrations. Remarkably, even at 1,000-fold dilution of the lysates SiMPull detected YFP-mTOR specifically (Fig. S2A ), whereas at 100-fold dilution of the same lysates, there was no longer any signal on Western blots (Fig. S2B) . Furthermore, in SiMPull, we were able to detect YFP-mTOR pulled down via endogenous raptor using a 100-fold dilution of the lysate (Fig. S2 C and D) , whereas no signal was detected in conventional coimmunoprecipitation using the same dilution of lysate and raptor antibody (Fig. S2E) ; SiMPull required only 50 μL of the extract as opposed to 500 μL used for the corresponding coimmunoprecipitation. Hence, the SiMPull method is highly sensitive compared with conventional biochemical methods.
We then analyzed the fluorescence time trajectories of YFPmTOR pulled down with raptor. Most molecules (96%) bleached in either one or two steps, indicating that mTORC1 contains one or two molecules of fluorescently active YFP-mTOR (Fig. 1E) . Nearly 60% of the molecules exhibited two-step bleaching, whereas 36% bleached in a single step. The molecules bleaching in two steps were nearly twice as bright as one-step bleachers on average, indicating a reliable classification based on photobleaching steps (Fig. 1E ). Previous studies have determined that fluorescent proteins may not all mature to completion and the fraction of fluorescently active YFP is ∼75% (15, 16) . In a calibration experiment, photobleaching step distribution of monomeric and dimeric YFP or a mixture of the two proteins was measured, which revealed that the fraction of two-step photobleaching spots is linearly proportional to the fraction of dimeric YFP included ( Fig. 1 H and I) . A comparison of the observed photobleaching step distribution of YFP-mTOR in mTORC1 to the calibration data suggested that nearly all mTORC1 complexes (>95%) contain two copies of YFP-mTOR, assuming the maturation level of YFP for all experiments is the same.
We also transiently coexpressed YFP-mTOR and HA-raptor, which assembled into functional mTORC1 complexes (Fig. S1B ). Single-molecule fluorescence photobleaching analysis for YFPmTOR pulled down with HA-raptor revealed that the complexes each contained two copies of YFP-mTOR ( Fig. S3 A and B) . Similarly, when YFP-raptor and Flag-mTOR were coexpressed ( Fig. S1 C and D), two copies of YFP-raptor were found in each mTOR-raptor complex (Fig. 1 F and G) . Additionally, the mTORC1 inhibitors PRAS40 and DEPTOR were also present in two copies per mTORC1 (Figs. S1 E-G and S3 C-F).
To confirm that the complexes captured via SiMPull represent physiological state of mTORC1 and are not assembled/disassembled upon cell lysis, we followed the strategy of Riley et al. (17) and mixed lysates from cells expressing YFP-raptor and Flag-mTOR separately, and compared them to lysates of cells coexpressing the same proteins at similar expression levels ( Fig.  S3G ). At least 10-fold more mTORC1 complexes were detected in the lysates from cotransfected cells than the mixed lysates (Fig. S3H) . Similar results were obtained when intact cells were mixed before lysis (Fig. S3I) . Thus, postlysis association of mTORC1 components does not significantly contribute to the complexes detected here via SiMPull.
SiMPull requires dilution of cell lysates to achieve low pulldown density suitable for single-molecule analysis, which could lead to loss of weakly associated physiological complexes. To address this issue, we treated YFP-mTOR-expressing cells with the cross-linker dithiobis(succinimidylpropionate) (DSP) before cell lysis. Lysis of cells using a Triton X-100-containing buffer disrupted mTORC1 complexes as expected (18), whereas DSP cross-linking before cell lysis preserved the complex under the same lysis condition (Fig. S4 A and B) , validating our cross-linking conditions. Importantly, cross-linked mTORC1 complexes exhibited a photobleaching step distribution corresponding to that of a dimer (Fig. S4C) , suggesting that the physiological complexes are intact during SiMPull analysis without cross-linking. In summary, we find that mTORC1 is dimeric, containing two copies of each component. These findings are consistent with the previous cryo-EM data (11), thus validating our experimental system for analysis of mTOR complexes by SiMPull.
mTORC2 Is Dimeric. mTORC2 assembly requires mSin and mLST8 (14, 19) in addition to mTOR and rictor, but the oligomeric state of mTORC2 is under debate (7, 10, 13, 14) . When all four core components of mTORC2 (mTOR, rictor, mSin, and mLST8) were coexpressed, each component self-associated as indicated by coimmunoprecipitation of the recombinant protein with two different tags ( Fig. 2A and Fig. S5A ), suggesting that assembled mTORC2 is oligomeric. To determine the oligomeric state of mTOR in mTORC2, we captured mTORC2 complexes from the YFP-mTOR stable cell line on SiMPull surfaces using an antibody against endogenous rictor (Fig. 2B) . Intriguingly, once again we observed a photobleaching pattern characteristic for dimeric YFP-mTOR (Fig. 2C) . Similar results were obtained when YFPmTOR was coexpressed with recombinant mTORC2 components ( Fig. S6 A and B) , which also assembled into functional mTORC2 (Fig. S5 B and C) .
Next, we probed the stoichiometry of rictor in mTORC2. YFPrictor was coexpressed with Flag-mTOR, mSin-HA and HAmLST8, and the assembly of mTORC2 was verified by ensemble pulldown (Fig. S5 D and E) . Upon single-molecule pulldown of mTORC2 via Flag-mTOR (Fig. 2D) , we observed YFP-rictor photobleaching consistent with two copies of rictor per mTORC2 (Fig. 2E) . Furthermore, YFP-DEPTOR in mTORC2 was found to display photobleaching distribution that corresponded to a mixture of monomers and dimers (∼60% dimer) (Fig. S6 C and D) , indicating that each mTORC2 can harbor up to two copies of DEPTOR.
Once again, cell mixing ( Fig. S6 E and F) and DSP crosslinking ( Fig. S6 G and H) experiments were performed, the results of which confirmed that the dimeric stoichiometry most likely reflects physiological assembly of mTORC2 in live cells. In conclusion, our results unequivocally reveal mTORC2 as a dimer, in which each subunit is present in two copies. Biochemical characterizations so far suggest that mTORC1 and mTORC2 are mutually exclusive, but functional cross-talk between these two complexes at multiple levels is increasingly apparent (20) (21) (22) . Even a small fraction of mTORC1/mTORC2 cocomplex could be functionally significant, but may have escaped detection by conventional biochemical methods. Multicolor SiMPull should allow direct visualization of such hybrid complexes, if any. As a positive control, we coexpressed FlagmTOR, mCherry-raptor, and YFP-PRAS40. Upon capturing Flag-mTOR, we observed both mCherry-raptor and YFP-PRAS40 fluorescence spots (Fig. 3A) ; ∼49% of YFP-PRAS40 spots colocalized with mCherry-raptor, indicating their coexistence in the same complexes. Incomplete colocalization between the two likely arises from incomplete chromophore maturation (∼40% for mCherry and ∼75% for YFP) (23, 24) and the participation of endogenous untagged proteins.
Next, we coexpressed mCherry-raptor and YFP-rictor together with Flag-mTOR, mLST8, and mSin. An anti-Flag antibody captured both mTORC1 and mTORC2 as visualized by mCherry and YFP fluorescent spots, respectively, and about 7% of mCherry-raptor spots reproducibly colocalized with YFPrictor (Fig. 3B) . Taken into consideration the incomplete chromophore maturation mentioned above, it is likely that the true fraction of the mTORC1/mTORC2 cocomplex is higher than 7%. Under these experimental conditions, the colocalization by chance was ∼1% (Fig. S7A) . Additionally, when YFP instead of YFP-rictor was expressed, only a background level of YFP fluorescent spots was observed upon Flag-mTOR pulldown, and these spots did not colocalize with mCherry-raptor (Fig. S7B) . Importantly, raptor coexpression did not alter mTORC2 stoichiometry, as rictor was still present in two copies (Fig. S7C) .
To verify that the hybrid complex was not an artifact of cell lysis, we performed cell mixing experiments. mTORC1 components (Flag-mTOR and mCherry-raptor) and mTORC2 components (Flag-mTOR, YFP-rictor, mSin-HA, and HA-mLST8) were expressed in two separate pools of cells, which were mixed during lysis (Fig. S7 D-F) . After accounting for false colocalization by chance, only 2% colocalization between mCherry-raptor and YFP-rictor was observed from mixed lysates. Therefore, although the two mTOR complexes are predominantly distinct, hybrid mTOR complexes containing both raptor and rictor or higher order assemblies of mTORC1/mTORC2 exist, albeit at a low level.
mTORC1 and mTORC2 Components Are Monomeric. Because both mTORC1 and mTORC2 are dimeric, we asked if mTOR or other core components could self-dimerize. To that end, each component tagged with YFP was individually expressed. When YFP-mTOR was captured using an anti-mTOR antibody, nearly 75% of the molecules bleached in a single step, whereas 20% bleached in two steps, indicating that a majority of overexpressed mTOR was monomeric (Fig. 4A) . Furthermore, when YFP-mTOR and HA-mLST8 were coexpressed and the mTOR-mLST8 subcomplexes were captured through the HA tag, a photobleaching step distribution characteristic of monomers was observed for YFPmTOR (Fig. 4B) . Similar analysis for HA-YFP-raptor and HA-YFP-rictor, pulled down through the HA tag, also revealed monomeric distributions (Fig. 4 C and D) . In addition, YFP-PRAS40 bound to raptor was monomeric (Fig. S8 A and B) . The observed small fractions of dimer may arise due to incorporation of YFPtagged proteins in endogenous mTOR complexes. Taken together, our results show that although both mTORC1 and mTORC2 are exclusively dimeric, individual mTORC components and subcomplexes are predominantly monomeric. Thus, no single mTORC subunit serves as a dimerizing component.
mTORC Stoichiometry Is Unchanged Under Various Physiological
Conditions. Next we asked if the oligomerization of mTOR complexes was affected by upstream signals or physiological conditions known to regulate mTOR signaling, including growth factors, nutrient availability, and cellular energy levels. To examine the effect of energy sufficiency, we starved the YFPmTOR stable cells of glucose and glutamine, which leads to energy depletion and inhibition of mTORC1 signaling (12) , and briefly (1 h) restimulated them with growth medium containing glucose and glutamine. As shown in Fig. 5A , a nearly equal number of mTORC1 complexes pulled down through endogenous raptor were detected by SiMPull, with similar photobleaching step distribution, under starvation and stimulation conditions. Similarly, neither amino acids (Fig. 5B) nor leucine (Fig. S8 C and D) stimulation had any effect on the number or stoichiometry of mTORC1. In addition, insulin stimulation did not affect mTORC1 (Fig. 5C) or mTORC2 assembly (Fig. 5D) . The starvation and stimulation conditions impacted mTOR signaling as expected (Fig.  1B and Fig. S1A ). These observations directly establish that inhibition of mTOR activity by energy stress or nutrient-or growthfactor depletion can be achieved without disassembly of the mTOR complexes.
Effect of Rapamycin on mTOR Complexes. Several models have been proposed for the mechanism by which rapamycin inhibits mTOR. For example, rapamycin may limit substrate access to the kinase domain (25, 26) , may induce raptor dissociation from mTOR (11, 18, 27) , or displace a key regulator (28) . We investigated the effect of rapamycin on the stoichiometry of mTOR complexes. As reported (29), short-term treatment of cells with rapamycin dissociated raptor from mTOR and inhibited mTORC1 signaling, whereas on prolonged treatment, mTORC2 assembly was also affected (Fig. S9 A and B) . When YFP-mTOR stable cells were treated with increasing concentrations of rapamycin (2-100 nM) for 30 min and mTORC1 complexes were captured from cell lysates through endogenous raptor, the number of YFP-mTOR pulled down decreased with increasing rapamycin dose (Fig. 6A) : treatment with 2 nM of rapamycin led to reduction by 56%, and a maximal reduction of ∼90% was reached by 10 nM and 100 nM rapamycin (Fig. 6C) . The residual mTORC1 appeared to be resistant to rapamycin, consistent with previously reported observations (18) . Thus, acute rapamycin treatment at low dose disrupted the interaction between mTOR and raptor.
Additionally, we found that the fraction of dimers decreased as the rapamycin dose was increased. At 2 nM of rapamycin, about 47% of the molecules bleached in two steps, whereas at 100 nM, only 29% of the molecules exhibited two-step bleaching (Fig. 6B) . The photobleaching analysis was performed at similar surface densities of the complexes (∼0.1 molecules·μm
), precluding any artifacts due to differences in the immobilization density. This observation of transient monomeric mTOR-raptor complexes indicates that rapamycin disrupts mTORC1 in at least two steps, displacing one mTOR (or mTOR-raptor monomeric subcomplex) at a time. Consistent with these results, mTOR bound to FKBP12-rapamycin is monomeric, as indicated by the single-step photobleaching exhibited by YFP-mTOR pulled down via surface immobilized FKBP12-rapamycin (Fig. S8 E  and F) . The reduction in mTORC1 signaling activity (pS6K1) corresponded with the loss of intact dimeric mTORC1 complexes (Fig. 6C) , implying that disruption of mTORC1 dimeric architecture contributes significantly to rapamycin-induced abrogation of mTORC1 signaling.
Next, we investigated the effect of prolonged rapamycin treatment on mTORC2 assembly by capturing endogenous rictor from YFP-mTOR cell lysates. The number of mTORC2 complexes decreased by 40% upon 6-h treatment with 100 nM of rapamycin and was reduced by 79% after 24 h (Fig. 6D) . Interestingly, in contrast to the transient mTORC1 monomers, mTORC2 remained a dimer at all time points (Fig. 6E) . Rapamycin treatment did not affect mTOR expression levels ( Fig. S9 C and D) , whereas the amount of mTORC1 decreased (Fig. S9E) . Thus, our results suggest that rapamycin does not directly affect mTORC2 stoichiometry. Instead, rapamycin may sequester free mTOR and subsequently impair mTORC2 assembly over time.
Discussion
Using SiMPull we have determined the stoichiometry and assembly of mTOR complexes captured from whole cell lysates. In addition to confirming the dimeric structure of mTORC1 as previously revealed by cryo-EM studies, we find that mTORC2 assembles into a dimer, with two copies of each subunit. Interestingly, all individual subunits of mTORCs including mTOR, when expressed alone, are monomeric. This excludes a commonly presumed role of the HEAT repeats in mediating mTOR self-association. Interaction between mTOR and raptor alone is sufficient to form mTORC1 dimers, but mTORC2 assembly and dimerization require coexpression of mSin and mLST8 in addition to mTOR and rictor. Under physiological conditions, there is no evidence of monomeric interaction between mTOR and raptor or mTOR and rictor. Hence, we propose a model for mTORC assembly where the interaction between monomeric subunits is unstable; assembly requires multiple subunits to accumulate at high local concentrations (Fig. 6F) , which may be facilitated by membrane localization, subcellular compartmentalization, or scaffolding proteins. The small but significant fraction of mTORC1-mTORC2 cocomplex revealed by SiMPull suggests a potential physical cross-talk between the two complexes that may have evaded detection by conventional biochemical methods. Future investigation examining the biological function of this cocomplex is warranted.
Of significance, our SiMPull assays have captured the existence of monomeric mTORC1 (mTOR-raptor complex) upon acute rapamycin treatment, before complete disruption of the mTOR-raptor interaction (Fig. 6F) . The capture of this intermediate state of mTORC1, which was not detected by cryo-EM analysis (11) , further attests to the exquisite sensitivity of the SiMPull method. We also provide direct evidence that cellular stress conditions that abrogate mTORC1-or mTORC2-mediated signaling do not alter the number or oligomerization state of mTOR complexes, indicating that effective inhibition of mTOR signaling can be achieved without disassembling mTOR complexes. Of note, Kim et al. recently reported that glucose and glutamine deprivation results in monomeric mTORC1 (12) , which Individual mTORC components are monomeric and assemble into homodimeric holocomplexes, mTORC1 or mTORC2. Rapamycin directly disrupts the mTOR-raptor interaction leading to monomeric mTORC1 and single proteins. Rapamycin-FKBP12-associated mTOR cannot be incorporated into mTORC1 or mTORC2, resulting in indirect depletion of mTORC2 over time.
is not observed in our SiMPull assays. Again, direct experimentation with fresh cell lysates containing near-endogenous proteins, without any additional manipulation such as those required for conventional coimmunoprecipitation, may be advantageous in capturing physiologically relevant protein complexes. Dimerization of other PIKKs such as ATM and DNA-PK play important roles in the regulation of their activities (4, 6) . Our data reveals differences in assembly mode and regulation of mTOR compared with these members of the PIKK family. Over 75% of the proteins in a cell can oligomerize (30) . SiMPull is a powerful method to investigate oligomeric protein assemblies. This method provides direct and quantitative readout of the assembly state of the proteins, expressed at endogenous levels directly in their native context. Proteins are captured from freshly lysed cells and probed at single-molecule resolution without requiring removal of other proteins, minimizing loss of interactions due to stringent wash steps associated with conventional immunoprecipitation. SiMPull worked wherever ensemble immunoprecipitation worked across the variety of constructs and samples tested in this study, highlighting the versatility of the assay. By performing SiMPull and biochemical analysis on the same samples, we were able to correlate the complex architecture with its functional activity. The advent of genetic engineering at endogenous loci and developments in short genetically encoded fluorescent tags should enable powerful applications of this technology to near-endogenous systems.
Materials and Methods
Antibodies, Plasmids, and Other Reagents. These are all described in SI Materials and Methods.
Cell Culture. The maintenance and transfection of HEK293 cells, and the generation of YFP-mTOR stable cells are described in SI Materials and Methods.
Single-Molecule Analyses. Single-molecule imaging and spot counting, photobleaching analysis, and single-molecule colocalization were performed as previously reported (15, 31) . Detailed procedures are described in SI Materials and Methods.
Western Blotting, Immunoprecipitation, and in Vitro mTOR Kinase Assays. These assays followed previously published procedures (32) and are described in detail in SI Materials and Methods.
Statistical Analysis. All data are presented as mean ± SD, or representative images, of at least three sets of independent experiments. Whenever necessary, statistical significance of the data was analyzed by performing onesample or paired t tests.
